Cancer BiologybioRxiv
KRAS inhibition activates an actionable CD24 do-not-eat-me signal in pancreatic cancer
Y. Wei, M. Liu, E.-Y. Yen…·H. Ying
This study identifies CD24 as an actionable signal activated by KRASG12C inhibition in pancreatic cancer, enhancing macrophage phagocytosis and sensitizing tumors to therapy.
DOI 10.1158/0008-5472.can-25-2024